Team at Harvard plans to launch a clinical trial for a potential COVID-19 vaccine in the fall.

Further research and development on a class of molecules called bisphosphonates might turbocharge a vaccine against SARS-CoV-2, the novel coronavirus, and help bring immunity to huge populations more quickly.